AnaptysBio

AnaptysBio(ANAB)

SAN DIEGO, CA
Biotechnology
WebsiteLinkedInCareers Page

Focus: Antibody Therapeutics

AnaptysBio is a life sciences company focused on Antibody Therapeutics.

Oncology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020
Asthma
N/A
Clinical Trials (1)
NCT04256044Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020
N/A
Phase 2
Clinical Trials (1)
NCT03469934Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma
Phase 2
Phase 2
Clinical Trials (1)
NCT06127043A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
Phase 2
Phase 2
Clinical Trials (1)
NCT03614923Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Phase 2
Phase 2
Clinical Trials (1)
NCT05935085This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
Phase 2
Phase 2
Clinical Trials (1)
NCT02920021Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy
Phase 2
Phase 2
Clinical Trials (1)
NCT03533751Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2
Rosnilimab
Alopecia Areata
Phase 2
Clinical Trials (1)
NCT05205070A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
Phase 2
Phase 2
Clinical Trials (1)
NCT06041269A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2013
Portfolio: 9 clinical trials
SEC Filings: 2 available

Financials (FY2025)

Revenue
$17M67%
R&D Spend
$132M(771%)49%
Net Income
-$164M
Cash
$123M
Source: SEC 10-K Filing

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 3 crawl cycles